Healthcare issues

Health savings account participants are more engaged in their healthcare decisions but still see HSAs as ways for reducing medical expense.

Injectable drugs and in-patient care drive the highest of cost for employers.

Injectable drugs and in-patient care drive the highest of cost for employers.

Owning a home offers some benefits, such as the option for a reverse mortgage and certain tax breaks, but are they enough to offset the burdens involved.

The final ruling includes protections intended to remedy historical challenges with AHPs and to prevent AHPs from discriminating against individuals based on health reasons.

The online retail giant’s purchase of the e-pharmacy may deliver convenience but who will monitor customers for side effects and wrong dosages?

As the new head of Amazon, Berkshire and JPMorgan’s healthcare venture gets down to work, we can see what his plans might be for the future of large employer health plans.

The online retail conglomerate takes another step into the health market with its announcement to buy PillPack, surprising several industry leaders.

The online retail conglomerate takes another step into the healthcare market with its announcement to buy online pharmacy, surprising several industry leaders.

Attempting to circumvent the costly specialty drug chain, brokers are encouraging clients to shop for FDA-approved drugs outside the U.S.

The health venture established will take aim at intermediaries in the healthcare system as a part of a broad effort to reduce wasteful spending

The world’s biggest pharmaceutical companies, looking to sell a new type of cancer drug that could transform treatment, are grappling with an unusual challenge: finding patients.

The CEO of the Amazon-JPMC-Berkshire Hathaway aims to address the “tapeworm” eating the U.S. economy.

Atul Gawande, the surgeon and journalist who has written extensively about America’s failure to grapple with an inefficient healthcare system, has been named to head a new venture for Amazon, Berkshire Hathaway and JPMorgan Chase.

From the opioid epidemic to alcoholism, executives can play an important role in creating a culture and leading a conversation around abuse prevention.

Firms such as AIMM and Claim DOC are showing brokers and employer clients just how costly claims are becoming and where to find alternative avenues of care.

A 1,000-person firm could lose more than $80,000 annually to migraine-related health costs and lost work time according to a new report out from the Integrated Benefits Institute.

A 1,000-person firm could lose more than $80,000 annually to migraine-related health costs and lost work time according to a new report out from the Integrated Benefits Institute.

Advisers must guide employers to the right solutions partner who can help them evaluate the best care based on reliable population health data.

Midwest Benefit Advisors works with a medical management firm to help plan participants make smart, cost-saving healthcare decisions.